RxDoctor Payments Data

David Carpenter, MD

Obstetrics & Gynecology · Mobile, ALNPI 1760422075

Payments from drug & device makers

$2,574in general payments, 2019–2025

Across 156 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$503
  • Sumitomo Pharma America, Inc.$346
  • Bayer$289
  • Mayne Pharma Commercial LLC$188
  • AbbVie$144
  • Mylan Pharmaceuticals Inc.$100
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,55899%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,574 in reported general payments places this provider in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.

See all obstetrics & gynecology providers in Alabama

Medicare billing

Part B allowed, 2024
$17,067
Medicare patients
205
Services billed
2,439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated59$25,845
Estradiol682$20,185
MyrbetriqMirabegron12$9,736
Estradiol (Twice Weekly)Estradiol52$6,101
Tolterodine Tartrate ErTolterodine Tartrate29$5,862
PremproEstrogen,con/M-Progest Acet17$5,654
Oxybutynin Chloride ErOxybutynin Chloride223$4,969
Risedronate Sodium12$2,941
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet109$2,716
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet24$2,322
Raloxifene Hcl34$1,761
ValacyclovirValacyclovir Hcl22$1,523
Venlafaxine Hcl ErVenlafaxine Hcl52$1,173
Alendronate Sodium119$945
Clobetasol Propionate27$823

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin, Prempro$41$31,49876 claims
Astellas Pharma US IncMyrbetriq$503$9,73612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.

Other obstetrics & gynecology in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →